Global Irritable Bowel Syndrome (IBS) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Irritable Bowel Syndrome (IBS) market size will reach 7,666.66 Million USD in 2025 and is projected to reach 19,817.14 Million USD by 2032, with a CAGR of 14.53% (2025-2032). Notably, the China Irritable Bowel Syndrome (IBS) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, changes in bowel habits, and discomfort. IBS is considered a functional gastrointestinal disorder, meaning there is no structural abnormality or damage to the digestive tract. The exact cause of IBS is not well understood, but factors such as abnormalities in the gut-brain axis, hypersensitivity of the intestines, and changes in gut motility may contribute to its development. IBS can be categorized into different subtypes based on predominant symptoms, such as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or mixed-type (alternating between constipation and diarrhea). Diagnosis is typically based on the presence of characteristic symptoms, and healthcare providers may recommend dietary changes, medications, and lifestyle modifications to manage symptoms. Although IBS can be a chronic condition, it does not lead to serious complications or increase the risk of other gastrointestinal diseases. Management strategies are focused on alleviating symptoms and improving the quality of life for individuals with IBS.

The major global suppliers of Irritable Bowel Syndrome (IBS) include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Irritable Bowel Syndrome (IBS). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Irritable Bowel Syndrome (IBS) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Irritable Bowel Syndrome (IBS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Irritable Bowel Syndrome (IBS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Irritable Bowel Syndrome (IBS) Include:

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Irritable Bowel Syndrome (IBS) Product Segment Include:

IBS-D Drug

IBS-C Drug

Others

Irritable Bowel Syndrome (IBS) Product Application Include:

Women

Men

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Irritable Bowel Syndrome (IBS) Industry PESTEL Analysis

Chapter 3: Global Irritable Bowel Syndrome (IBS) Industry Porter's Five Forces Analysis

Chapter 4: Global Irritable Bowel Syndrome (IBS) Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Irritable Bowel Syndrome (IBS) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Irritable Bowel Syndrome (IBS) Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Irritable Bowel Syndrome (IBS) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources